US 11427646
Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis
granted A61KA61K45/06A61P
Quick answer
US patent 11427646 (Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis) held by B CELL DESIGN expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- B CELL DESIGN
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00